Midgard Science

Celerion

Saint-Laurent, QC, Canada celerion.com From their website, Nov 2026

  • CLIA

Work here? Claim this listing

About

Celerion is an early-phase clinical research CRO that supports drug development for pharmaceutical and biotech companies. It provides clinical, bioanalytical, regulatory, biometrics, and modeling services from sites in Phoenix, Lincoln, Belfast, and Zurich. The company focuses on helping sponsors make earlier go/no-go decisions in Phase I and clinical pharmacology studies.

Services

  • Early Phase Clinical Research

    Provides comprehensive Phase I and clinical pharmacology services for early drug development programs.

  • Bioavailability / Bioequivalence Studies

    Conducts BA/BE studies for generic drug development and regulatory submissions.

  • Drug-Drug Interaction (DDI) Studies

    Runs interaction studies for complex multi-compound protocols and NDA-enabling programs.

  • Single Ascending Dose / Multiple Ascending Dose Studies

    Performs SAD/MAD and first-in-human dose escalation studies.

  • Food Effect Studies

    Evaluates the effect of food on drug performance in early clinical studies.

  • Thorough QT (TQT) Studies

    Conducts cardiac safety studies to assess QT interval effects.

  • Radiolabeled (ADME) Studies

    Performs radiolabeled absorption, distribution, metabolism, and excretion studies.

  • Pharmacodynamic (PD) Studies

    Carries out pharmacodynamic studies in early-phase development.

12 more services
  • Monitoring & Project Management
  • Bioanalytical Sciences
  • Pharmacokinetics / Pharmacodynamics (PK/PD) Analysis
  • Immunogenicity
  • Biomarkers
  • Biosimilars
  • Gene Therapy
  • Metabolite Identification and Profiling
  • Data Management & Biometric Services
  • Modeling and Simulation Services
  • Clinical Protocol Development
  • Biostatistical Analysis
Turnaround
24 hours
What to send
  • Investigational product
  • Interactive medications

Capabilities

Assays and studies
  • PK/PD
  • Bioanalysis
  • Immunogenicity
  • ADME
  • Bioavailability
  • Bioequivalence
9 more
  • Drug-drug interaction
  • Single ascending dose
  • Multiple ascending dose
  • Food effect
  • Thorough QT
  • Radiolabeled ADME
  • Pharmacodynamic
  • Biomarker
  • Metabolite identification
Scale and capacity
  • More than 650 beds worldwide
  • Sites in Phoenix, Arizona
  • Sites in Lincoln, Nebraska
  • Sites in Belfast, UK
  • Sites in Zurich, Switzerland
  • 24/7 STAT testing available
Therapeutic areas
  • Respiratory disease
  • Metabolic disorder
  • Biosimilar clinical research
  • Renal impairment
  • Hepatic impairment
  • Cardiovascular safety
  • Cardiovascular efficacy
  • Tobacco harm reduction

Instruments and platforms

  • ECG Core Lab
  • Electronic Data Capture (EDC)
  • Electronic Trial Master File (eTMF)
  • E-Lab Notebook
  • Celexus®
  • ClinQuick®

Modalities and species

Modalities
  • Small molecule
  • Biosimilar
Species and models
  • CAP/CLIA-accredited clinical laboratory
  • USP-compliant compounding suites

Industries served

  • Pharmaceutical
  • Biotech
  • Generic drug development

Details

Type
CRO
Office
delivering 21 CFR Part 11 validated systems with real-time data visualiza
Sites
  • Phoenix, United States
  • Lincoln, United States
  • Belfast, United Kingdom
  • Zurich, Switzerland
Serves
Global

Similar labs